Pancreatic Cancer Research

Journal articleEur Rev Med Pharmacol Sci2019

MiR-223 regulates CDDP resistance in pancreatic cancer via targeting FoxO3a.

Journal
Eur Rev Med Pharmacol Sci
Published
1 September 2019
Citations
17
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Objective FoxO3a is a well-defined tumor suppressor gene in the forkhead transcription factor O subfamily (FoxO), and its reduction is related to the occurrence of various tumors. It was found that miR-223 expression is abnormally elevated in pancreatic cancer tissues. … Excerpt only: this text is the publisher’s. Read it in full at the source.